Home Cart Sign in  
Chemical Structure| 1883602-21-8 Chemical Structure| 1883602-21-8

Structure of TES-1025
CAS No.: 1883602-21-8

Chemical Structure| 1883602-21-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TES-1025 is a potent and selective human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD) inhibitor with an IC50 of 13±3 nM.

Synonyms: TES-1025

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TES-1025

CAS No. :1883602-21-8
Formula : C18H13N3O3S2
M.W : 383.44
SMILES Code : O=C(O)CC1=CC=CC(CSC2=NC(C3=CC=CS3)=C(C#N)C(N2)=O)=C1
Synonyms :
TES-1025
MDL No. :MFCD31657384
InChI Key :RJQYGCGMQYVVIB-UHFFFAOYSA-N
Pubchem ID :137142885

Safety of TES-1025

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse primary hepatocytes 500 nM 24 hours Increased NAD+ content, activated SIRT1 activity, and enhanced mitochondrial function Nature. 2018 Nov;563(7731):354-359
HK-2 cells 100 µM 24 hours Increased NAD+ content, induced transcript levels of mitochondrial and ROS defense genes, increased ATP content, and protected cells from cisplatin-induced apoptosis Nature. 2018 Nov;563(7731):354-359

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Cisplatin-induced acute kidney injury model Oral 15 mg/kg/day Once daily for 10 days Protected kidneys from cisplatin-induced injury, increased renal NAD+ content, and improved renal function Nature. 2018 Nov;563(7731):354-359
Zebrafish Ethanol-induced acute hepatic injury model Water solution administration 192 μg/L 2 days TES-1025 suppressed ethanol-induced serum ALT levels, increased hepatic NAD+ levels, and protected hepatocytes from ethanol-induced acute hepatic injury. Biomed Pharmacother. 2020 Dec;132:110836

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.04mL

2.61mL

1.30mL

26.08mL

5.22mL

2.61mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories